Cherry Sunrise is a CBD-forward hybrid with a distinctly gentle indica bias, about 60% indica to 40% sativa. It results from crossing Cherry OG with Early Bird, yielding a plant that carries a notably low psychotropic kick but a pronounced therapeutic potential. With THC hovering around 0-1% and CBD typically in the 9-13% range, this cultivar delivers a 1:20 ratio that emphasizes calming relief without a heavy high.
On inhalation, the experience is characterized by a soft mental lift paired with steady physical relaxation. The toke tends to soothe aches and tensions while keeping the mind present, avoiding intense stimulation or overdrive. For those who need deeper rest, a touch of sleepiness may settle in as the body settles, particularly when fatigue is calling.
The aroma blends earthy pine with a berry-edged citrus and a sweet-tart cherry note, finishing with a fresh fruity profile. Visually, the buds are long, tapered, spade-shaped on a forest-green canvas and accented by dark olive undertones, thin amber hairs, and bright white crystal trichomes. This indica-dominant line is commonly explored for managing chronic pain, depression, insomnia, fibromyalgia, bipolar disorder, and glaucoma-related eye pressure, offering relief without pronounced intoxication and with a flavor profile that lingers on the palate.